Fig. 2From: A new perspective on NO pathway in sepsis and ADMA lowering as a potential therapeutic approachThe potential benefits of ADMA lowering based on the preclinical studies and the adverse effects of L-NAME observed in clinical trials. ROS: reactive oxygen species, MPAP: Mean pulmonary arterial blood pressure, PVR: Pulmonary vascular resistance, MPA: Mean arterial pressureBack to article page